National Strategic Plan for the Prevention and Control of Non-Communicable Diseases 2021/22 - 2025/26

Non-Communicable Disease National Health Strategy 2021
Kenya English PDF
National

AI-Generated Document Summary

Objectives

Kenya’s National Non-Communicable Disease Strategic Plan 2021/22–2025/26 provides a five-year framework to halt and reverse the rising burden of non-communicable diseases through multisectoral collaboration, while ensuring accessible, affordable, equitable, quality and sustainable care across the continuum. Its vision is a nation free from the preventable burden of non-communicable diseases, and its goal is to reduce premature mortality from these diseases by one third by 2025.

  • Address cardiovascular diseases, cancer, diabetes, chronic respiratory diseases, mental health conditions, violence and injuries, blood disorders, neurological disorders, autoimmune and chronic renal diseases, chronic skin conditions, and oral diseases.
  • Reduce exposure to tobacco, harmful alcohol use, unhealthy diets and toxins, physical inactivity, indoor and environmental air pollution, other pollutants and stress through a life-course approach.
  • Apply five strategic pillars: sectoral and multisectoral coordination and governance; reduction of modifiable risk factors; health-system response; advocacy, communication and social mobilisation; and surveillance, monitoring, evaluation and research.
  • Strengthen coordination and governance, equitable management across the life course, advocacy and social mobilisation, and research, surveillance, monitoring and evaluation.
  • Align interventions with the constitutional right to health, the Health Act 2017, Universal Health Coverage, Kenya Health Policy 2014–2030, Sustainable Development Goals and Vision 2030.
  • Achieve specific 2025 outcomes including lower diabetes prevalence, overweight and obesity, raised cholesterol, suicide, serious injuries and road-traffic mortality, alongside improved cardiovascular prevention, cancer screening, vaccination, diabetes and hypertension control, and availability of essential products and technologies.

Implementation

Implementation uses a whole-of-government, multisectoral and people-centred model spanning community, primary, secondary and tertiary care. The Ministry of Health leads the response with county governments, while communities, people living with non-communicable diseases, civil society, development partners, academia and private-sector actors participate in planning, delivery, monitoring and resource mobilisation.

  • Coordinate action through the National Non-Communicable Disease Steering Committee, the Non-Communicable Disease Intersectoral Coordination Committee, national and county health management structures, boards, committees and technical working groups.
  • Strengthen county coordination committees and technical working groups, maintain stakeholder databases, hold biannual steering forums, engage non-health sectors, operationalise work plans and establish a multisectoral information-management system.
  • Integrate prevention, screening, diagnosis, treatment, rehabilitation, palliative care and survivorship support into primary health care and Universal Health Coverage, supported by an essential non-communicable disease management package and an integrated primary health care model.
  • Build workforce capacity through training, deployment, retention measures, career pathways and optimised roles for nurses, allied professionals, community health assistants and community health volunteers, particularly in underserved areas.
  • Improve access to essential medicines, diagnostics, devices and assistive technologies through product-list reviews, quantification and costing, pooled procurement and price negotiations, pharmacovigilance, post-market surveillance and ring-fenced county commodity funds.
  • Deliver risk-factor action through legislation and fiscal measures on tobacco, alcohol, unhealthy foods, salt, trans-fats, sugar-sweetened beverages and environmental pollutants, alongside urban design, school, workplace, community and mass-media interventions.
  • Develop quality-improvement, telehealth, guideline and referral frameworks; establish county wellness centres of excellence and five additional regional comprehensive non-communicable disease centres by 2025.
  • Apply a Common Results and Accountability Framework with 15 high-impact indicators, baselines, targets and data sources; disaggregate reported data by sex and age; and undertake annual, mid-term and end-term reviews.
  • Strengthen surveillance through integrated electronic medical records, disease-specific registries, data tools, annual data-quality audits, population surveys and annual burden estimates.
  • Cost the strategy using Activity-Based Costing and the One Health Model, with a stated financing requirement of 377 billion Kenyan shillings over the plan period; quantify resource gaps by comparing required with available resources.
  • Mobilise resources through national and county budget processes, National Health Accounts, development-partner proposals, responsible private-sector engagement and advocacy for allocation of sin-tax revenue to non-communicable diseases.

Monitoring & Evaluation

The Strategic Plan establishes surveillance, monitoring, evaluation and research as one of its five pillars, supported by a monitoring, evaluation and learning framework and a Common Results and Accountability Framework (CRAF) for tracking implementation, results and accountability.

  • Measure progress against 15 high-impact indicators in the CRAF, with specified baselines, targets, data sources, collection methods, responsibilities, frequencies and review timelines.
  • Track impact indicators and targets for 2025/26, including the overall goal of reducing premature mortality from non-communicable diseases by one third by 2025.
  • Monitor service coverage, outcomes, patient outcomes, investment outputs, access to services and impacts through routine facility reporting, surveillance reports, health-data reviews, expenditure returns and periodic surveys.
  • Submit weekly surveillance reports, monthly facility reports by the fifth day of each month, quarterly reports and health-data reviews, annual work plans by the end of June, and annual performance reports and reviews between July and November.
  • Conduct annual reviews, a mid-term review and an end-term evaluation, while using an implementation tracking plan to follow up recommendations and feedback.
  • Strengthen surveillance through integrated electronic medical records, disease-specific registries, surveillance and patient-management tools, annual facility data-quality audits, population surveys including the STEPwise approach to NCD risk-factor surveillance, and annual burden estimates.
  • Disaggregate collected, analysed and reported data by sex and age to support gender integration and identify gender-related effects of programming.
  • Apply accountability through transparent joint data and performance reviews, social accountability, performance reporting, public awareness, public participation, resource-tracking tools and annual resource-accountability assessments.
  • Use data from the Kenya Health Information System, the NCD Navigator tool, National Health Accounts, committee and county reports, policy documents, surveys, registries and named administrative sources.

Key quantified targets include reducing diabetes prevalence from 1.9% to 1.7%, overweight and obesity from 27.9% to 25.8%, and serious injuries from 15% to 10% by 2025.Other targets include increasing cardiovascular preventive drug therapy and counselling coverage from 6.2% to 50%, essential product and technology availability to 80%, cervical cancer screening to 50%, human papillomavirus immunisation among 10-year-old girls to 90%, and diabetes and hypertension control to 40% and 50%, respectively.

The previous 2015–2020 strategy evaluation found that 19 of 109 activities were achieved, 75 partially achieved and 15 not achieved.The Plan responds by strengthening specific, measurable, achievable, relevant and time-bound indicators, process indicators, dissemination and routine data collection and reporting.

Costing & Financing

The Plan is costed to support resource mobilisation and adequate financing for non-communicable disease interventions, using Activity-Based Costing and the One Health Model where comprehensive quantification reports are unavailable.The reported total financing requirement is 377 billion Kenyan Shillings over the plan period.

  • Estimate costs by strategic pillar, quantify total resource requirements, project financial resources by funding source and analyse financial gaps for both the Strategy and Strategic Plan.
  • Determine resource gaps by comparing required with available resources, although the supplied material does not quantify available resources or the resulting gap.
  • Increase the government allocation to non-communicable diseases from a 2020 baseline of 10.9% to a 2025 target of 20% under the CRAF.
  • Increase the health ministry budget allocation for non-communicable disease interventions from a 2015 baseline of 6.5% to planned allocations of 11.5% in 2021, 16.5% in 2022, 21.3% in 2023, 26.5% in 2024 and 31.5% in 2025.
  • Develop national and county resource-tracking and accountability tools, conduct annual resource tracking, and improve non-communicable disease representation in National Health Accounts.
  • Mobilise resources through national and county budget advocacy, medium-term expenditure framework and annual budget processes, development-partner proposals, private-sector partnerships, sin-tax revenue advocacy and county resource-mobilisation frameworks.
  • Reduce patient costs through pooled procurement, negotiations on product and technology prices, review of taxation and pricing policies, and ring-fenced county commodity funds.
  • Quantify and cost essential health products and technologies to inform supply planning and affordability measures.

Non-communicable diseases are associated with a reported 28.6% reduction in household income and catastrophic expenditure that may contribute to poverty.An intervention package to mitigate their impact was estimated to require 17% of total health expenditure, or United States Dollars 11.97 per capita annually.

The supplied extracts identify financial transparency, inadequate national and county allocations, non-ring-fenced county budgets, limited financial protection and the lack of an essential chronic disease package as financing constraints.They do not provide a complete currency-denominated budget breakdown, quantified available resources, donor contributions or a final monetary funding-gap value.

Document Viewer